By understanding the molecular signaling pathways that lead to tumor formation, Prof. Ip and her team are identifying new targets for anti-cancer therapy, and developing new approaches to cancer treatment. Their work on new small-molecule drugs that can lead to increased cell death and reduced tumor formation holds promise for the development of new and more effective treatments for patients with colorectal cancer, breast cancer, melanoma and other types of cancer, giving doctors new options to save lives in generations to come.